SPOTLIGHT -
Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.
sNDA Submitted: Spravato as Monotherapy for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Which Antidepressant Causes the Least Amount of Weight Gain?
Treating ‘Morally Objectionable’ Patients
The Potential of Ketamine: Public Workshop and New Research Explores Uses
The Week in Review: June 17-21